No Results
"We are currently gathering more data to assess the safety of myaccess360.com. Your safety is our priority, and we're conducting a thorough analysis before providing a comprehensive evaluation."
The Access 360 program provides personal support to connect patients to affordability programs and streamline access and reimbursement for select AstraZeneca medicines.
Traffic rank of myaccess360.com, compared to all other sites
↑ 1.47M+
United States
Website ranking is crucial for evaluating myaccess360.com's stats. TopWeb.ai leverages cutting-edge techniques, including data gathering, collection, and analysis from diverse internet resources, to estimate website traffic. Our assessments are based solely on publicly available information, offering valuable insights into potential traffic trends without relying on business owner-provided data. Additionally, we utilize advanced tools like ChatGPT and Gemini API to enhance our evaluation process, ensuring accurate and comprehensive traffic estimations and analysis.
Over the last three months, myaccess360.com's global ranking has increased from 7,889,230 to 6,421,280.
Total Visits
Bounce Rate
Pages per Visit
Avg Visit Duration
Moz metrics are by Moz that predicts how well a specific page will rank.
WOT's security score derives from our partners and community-driven expert reviews
Amazon Alexa Rank provides a broad gauge of a website's online popularity.
The Organic Search section reveals valuable insights, including organic traffic and keywords for in Google's top 100 search results.
Explore alternative, competitive and similar websites to myaccess360.com based on traffic, content and site structure.
Review current patient savings programs for specialty products from AstraZeneca.
Astrazenecaspecialtysavings alternatives
The AZ&Me Prescription Savings program is designed to help qualifying patients, including those who receive their medications through participating healthcare facilities.
Azandmeapp alternatives
FASENRA is an add-on maintenance treatment for patients 12 and older who are diagnosed with severe eosinophilic asthma. Find out more about FASENRA and see if it is the right treatment for you.
Fasenra alternatives
Learn more about Fasenra® (benralizumab) for treatment of eosinophilic asthma in patients with severe asthma. Fasenra® is for patients 12 years or older with severe eosinophilic asthma.
Fasenrahcp alternatives
LYNPARZA® (olaparib) is a PARP inhibitor for first-line maintenance treatment for patients with BRCAm advanced ovarian cancer. LYNPARZA is also indicated for recurrent ovarian cancer and gBRCAm HER2-negative metastatic breast cancer.
Lynparzahcp alternatives
Parent and caregiver information for SYNAGIS, a therapy to help prevent a serious lung disease caused by respiratory syncytial virus (RSV) in children at high risk for severe lung disease from RSV.
Synagis alternatives
Cortizone 10 Anti-Itch Products
Cortizone10 alternatives
MIMS online, search the database of prescription and generic drugs, clinical guidelines and patient advice.
Mims alternatives
Medbase-apotheken alternatives
Cdncare alternatives
Check out some of our popular sites.